1). Okada AA, Johnson RP, Liles WC, et al. Endogenous bacterial endophthalmitis. Report of a ten-year retrospective study. Ophthalmology. 1994; 101:832–8.
2). Liang L, Lin X, Yu A, et al. The clinical analysis of endogenous endophthalmitis. Yan Ke Xue Bao. 2004; 20:144–8.
3). Durand ML. Endophthalmitis. Clin Microbiol Infect. 2013; 19:227–34.
4). Sridhar J, Flynn HW Jr, Kuriyan AE, et al. Endogenous fungal endophthalmitis: risk factors, clinical features, and treatment outcomes in mold and yeast infections. J Ophthalmic Inflamm Infect. 2013; 3:60.
Article
5). Sakata R, Numaga J. Fungal endophthalmitis in an elderly woman: differing responses in each eye. Int Med Case Rep J. 2017; 10:189–92.
Article
6). Liu YC, Cheng DL, Lin CL. Klebsiella pneumoniae liver abscess associated with septic endophthalmitis. Arch Intern Med. 1986; 146:1913–6.
Article
7). Connell PP, O'Neill EC, Amirul Islam FM, et al. Endogenous endophthalmitis associated with intravenous drug abuse: seven-year experience at a tertiary referral center. Retina. 2010; 30:1721–5.
8). Parke DW 2nd, Jones DB, Gentry LO. Endogenous endophthalmitis among patients with candidemia. Ophthalmology. 1982; 89:789–96.
Article
9). Samiy N, D'Amico DJ. Endogenous fungal endophthalmitis. Int Ophthalmol Clin. 1996; 36:147–62.
Article
10). Ku M, Jung JO, Lee DY, Nam DH. Endogenous Candida endophthalmitis with bilateral massive submacular abscess. J Korean Ophthalmol Soc. 2008; 49:1701–5.
Article
11). Sen P, Gopal L, Sen PR. Intravitreal voriconazole for drug-resistant fungal endophthalmitis: case series. Retina. 2006; 26:935–9.